首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >A high throughput neutralization test based on GFP expression by recombinant rabies virus
【2h】

A high throughput neutralization test based on GFP expression by recombinant rabies virus

机译:基于重组狂犬病病毒GFP表达的高通量中和试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effectiveness of rabies vaccination in both humans and animals is determined by the presence of virus neutralizing antibodies (VNAs). The Rapid Fluorescent Focus Inhibition Test (RFFIT) is the method traditionally used for detection and quantification of VNAs. It is a functional in vitro test for assessing the ability of antibodies in serum to bind and prevent infection of cultured cells with rabies virus (RABV). The RFFIT is a labor intensive, low throughput and semi-quantitative assay performed by trained laboratorians. It requires staining of RABV-infected cells by rabies specific fluorescent antibodies and manual quantification of fluorescent fields for titer determination. Although the quantification of fluorescent fields observed in each sample is recorded, the corresponding images are not stored or captured to be used for future analysis. To circumvent several of these disadvantages, we have developed an alternative, automated high throughput neutralization test (HTNT) for determination of rabies VNAs based on green fluorescent protein (GFP) expression by a recombinant RABV and compared with the RFFIT. The HTNT assay utilizes the recombinant RABV ERA variant expressing GFP with a nuclear localization signal (NLS) for efficient quantification. The HTNT is a quantitative method where the number of RABV-infected cells are determined and the images are stored for future analysis. Both RFFIT and HTNT results correlated 100% for a panel of human and animal positive and negative rabies serum samples. Although, the VNA titer values are generally agreeable, HTNT titers tend to be lower than that of RFFIT, probably due to the differences in quantification methods. Our data demonstrates the potential for HTNT assays in determination of rabies VNA titers.
机译:狂犬病疫苗在人和动物中的有效性取决于病毒中和抗体(VNA)的存在。快速荧光聚焦抑制测试(RFFIT)是传统上用于检测和定量VNA的方法。这是一项功能性体外测试,用于评估血清中抗体结合狂犬病病毒(RABV)并预防培养细胞感染的能力。 RFFIT是由训练有素的实验室人员执行的劳动密集型,低通量和半定量测定。它需要用狂犬病特异性荧光抗体对RABV感染的细胞进行染色,并手动定量荧光场以进行滴度测定。尽管记录了在每个样品中观察到的荧光场的定量,但没有存储或捕获相应的图像以用于将来的分析。为了避免这些弊端,我们开发了一种替代的自动化高通量中和测试(HTNT),用于通过重组RABV基于绿色荧光蛋白(GFP)的表达来确定狂犬病VNA,并将其与RFFIT进行比较。 HTNT测定法利用表达带有核定位信号(NLS)的GFP的重组RABV ERA变体进行高效定量。 HTNT是一种定量方法,可以确定RABV感染细胞的数量,并存储图像以供将来分析。对于一组人类和动物的狂犬病阳性和阴性狂犬病血清样品,RFFIT和HTNT结果均相关100%。尽管VNA滴度值通常是可以接受的,但HTNT滴度往往低于RFFIT的滴度,这可能是由于定量方法的差异。我们的数据证明了HTNT检测在确定狂犬病VNA滴度中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号